Drug-incorporating calcium carbonate nanoparticles for a new delivery system

Transdermal delivery of CaCO3-nanoparticles containing insulin

BACKGROUND

This study evaluates the pharmacokinetic and pharmacodynamic effects of a transdermally delivered insulin using novel CaCO(3)-nanoparticles in normal mice and those with diabetes.

METHODS

CaCO3-nanoparticles encapsulating insulin (nanoinsulin) were transdermally applied to the back skin of normal ddY mice and dB/dB and kkAy mice with diabetes after fasting for 1 h. Serum insulin levels of ddY mice were analyzed by enzyme immunoassay, and blood glucose of normal mice and those with diabetes was monitored.

RESULTS

Maximum serum insulin was 67.1 +/- 25.9 microIU/mL at 4 h with 200 microg of transdermal nanoinsulin in ddY mice, whereas that after subcutaneous injection of 3 microg of monomer insulin was 462 +/- 20.9 microIU/mL at 20 min. Transdermal nanoinsulin decreased glucose levels in a dose-dependent manner. A maximum decrease in blood glucose of 48.3 +/- 3.9% (ddY), 32.5 +/- 9.8% (dB/dB), and 26.2 +/- 7.6% (kkAy) after 6 h was observed with 200 microg of transdermal nanoinsulin, compared with 64.1+/-1.0% (ddY), 57.9 +/-3.4% (dB/dB), and 24.1 +/- 6.7% (kkAy) after 1 h with 3 microg of subcutaneous monomer insulin. Insulin bioavailability until 6 h with transdermal nanoinsulin in ddY mice was 0.9% based on serum insulin level and 2.0% on pharmacodynamic blood glucose-lowering effects.

CONCLUSIONS

This CaCO(3)-nanoparticle system successfully delivered insulin transdermally, as evidenced by a significant sustained decrease in blood glucose in normal mice and those with diabetes. These results support the feasibility of developing transdermal nanoinsulin for human applications.

Composite Phospholipid−Calcium Carbonate Microparticles: Influence of Anionic Phospholipids on the Crystallization of Calcium Carbonate

The synthesis and characterization of calcium carbonate microparticles by reaction of calcium chloride and ammonium bicarbonate in the presence of negatively charged phospholipid mixtures of negative and zwitterionic phospholipids has been reported. Negatively charged phospholipids influence the crystal morphology of calcium carbonate and induce the formation of thermodynamically less stable veterite polymorph as opposed to calcite polymorph. The phospholipids are entrapped in the calcium carbonate microparticles during the crystallization process, with a uniform distribution of phospholipids in the interior of the microparticles. This phenomenon was exploited to encapsulate a model hydrophobic fluorophore, the tris(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) dichloride complex, to simulate encapsulation of hydrophobic drug molecules. Thermogravimetric analysis reveals that, in these microparticles, the calcium carbonate and the phospholipid exhibit strong interactions.

DDS for anti-aging and regenerative medicine (review)

In this paper we summarized, first the present status and history of the development of research in anti-aging and regenerative medicine in Japan, and secondly some of our research using DDS in the field of both medicine. The regenerative medicine has been developed in Japan by using the fund from the Government, particularly as the Millennium Project. While anti-aging medicine developed following the social interest on it in Japan and it was influenced by American Society (A4M). Next, we summarized our research on DDS for anti-aging and regenerative medicine. In most cases we used oily or solid nanoparticles as carriers of drug. Those particles have a property of both of targeting and slow release in the DDS technology. The two properties are important for anti-aging and regenerative medicine, since drugs have to be administered safely and for long time. We applied prostaglandin E1, granulocyte-colony stimulate factor (G-CSF), and retinoid into the systems.